HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment.

Abstract
Angiogenesis and inflammation are pivotal processes in developing endometriosis in the peritoneal cavity. The aim of the present study was to evaluate these two processes in women with endometriosis who had been treated with danazol to determine the sensitivity of a non-invasive test in diagnosing endometriosis. The clinical follow-up study was conducted in a group of 103 women diagnosed laparoscopically with endometriosis. Thirty-five patients qualified for danazol treatment. Pain was assessed using a visual analogue scale, whereas endometriosis was assessed using the revised American Society of Reproductive Medicine (rASRM) scale. Cancer antigen (CA)-125 and C-reactive protein (CRP) concentrations in plasma and peritoneal fluid were determined by immunoenzymatic methods, whereas vascular endothelial growth factor (VEGF) and interleukin (IL)-1β concentrations in plasma and peritoneal fluid were determined by ELISA. Endometrial expression of IL-8 and platelet-derived growth factor alpha polypeptide (PDGF-A) was determined using real-time polymerase chain reaction (PCR). Women with endometriosis (68.9% of patients) had higher plasma concentrations of CA-125, as well as higher concentrations of both CA-125 and VEGF in the peritoneal fluid. Endometrial expression of IL-8 mRNA was significantly higher, whereas that of PDGF-A was significantly lower, in contrast. After danazol treatment the patients reported lower pain scores; in addition, CA-125 concentrations in the plasma were decreased (P<0.001), whereas VEGF concentration in the plasma increased (P=0.009). For the diagnosis of endometriosis, none of the combinations of given markers had a sensitivity >60%. Danazol treatment is highly effective in relieving pain and decreasing CA-125 concentrations in the plasma. Higher plasma concentrations of VEGF after treatment could imply stimulation of angiogenesis.
AuthorsM Szubert, J Suzin, M Duechler, A Szuławska, M Czyż, K Kowalczyk-Amico
JournalReproduction, fertility, and development (Reprod Fertil Dev) Vol. 26 Issue 3 Pg. 414-20 (Mar 2014) ISSN: 1031-3613 [Print] Australia
PMID23544741 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • CA-125 Antigen
  • Interleukin-1beta
  • Interleukin-8
  • Platelet-Derived Growth Factor
  • Vascular Endothelial Growth Factor A
  • platelet-derived growth factor A
  • C-Reactive Protein
  • Danazol
Topics
  • Ascitic Fluid (metabolism)
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • CA-125 Antigen (blood, metabolism)
  • Danazol (therapeutic use)
  • Endometriosis (diagnosis, drug therapy)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Inflammation (physiopathology)
  • Interleukin-1beta (blood, metabolism)
  • Interleukin-8 (metabolism)
  • Neovascularization, Pathologic (physiopathology)
  • Pain Measurement
  • Platelet-Derived Growth Factor (metabolism)
  • Real-Time Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Vascular Endothelial Growth Factor A (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: